2025-12-29 - Analysis Report
Okay, here's a comprehensive analysis of Linde PLC (LIN) based on the provided data, formatted as requested:

**1) Performance vs. S&P 500 (VOO)**

*   **LIN Overview:** Linde PLC is a global industrial gases and engineering company.
*   **LIN Cumulative Return:** 61.65%
*   **VOO Cumulative Return:** 103.21%
*   **Divergence:**
    *   Current: -40.5
    *   Relative Divergence: 11.5

*   **Analysis:** LIN has significantly underperformed the S&P 500 over the observed period. The current divergence of -40.5 indicates that LIN's return is significantly lagging behind the market. The relative divergence of 11.5 suggests the divergence is near its minimum historical value, indicating a potential oversold situation *relative to its own historical divergence*.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD    | Alpha  | Beta | Cap(B) |
|------------|--------|--------|--------|------|--------|
| 2015-2017  | 36.0%  | 9.2%   | 8.0%   | 0.0  | 72.5   |
| 2016-2018  | 27.0%  | 69.9%  | 12.0%  | 0.2  | 73.2   |
| 2017-2019  | 41.0%  | 69.9%  | 19.0%  | 0.4  | 99.8   |
| 2018-2020  | 14.0%  | 78.6%  | -10.0% | 0.4  | 123.6  |
| 2019-2021  | 63.0%  | 78.6%  | 16.0%  | 0.9  | 162.5  |
| 2020-2022  | 37.0%  | 78.6%  | 38.0%  | 0.8  | 153.0  |
| 2021-2023  | 43.0%  | 76.7%  | 41.0%  | 0.5  | 192.6  |
| 2022-2024  | 6.0%   | 76.7%  | -14.0% | 0.5  | 196.3  |
| 2023-2025  | -12.0% | 79.5%  | -80.0% | 0.5  | 199.2  |

*   **Analysis:**
    *   **CAGR (Compound Annual Growth Rate):** Performance has varied significantly, with strong growth periods (e.g., 2019-2021) and periods of decline (e.g., 2023-2025).  The most recent period shows a negative CAGR.
    *   **MDD (Maximum Drawdown):**  Drawdowns have generally increased over time, indicating higher potential risk.
    *   **Alpha:**  Alpha measures outperformance relative to a benchmark.  The recent negative Alpha values indicate significant underperformance. In particular, the period of 2023-2025 has a massive negative Alpha, indicating underperformance.
    *   **Beta:** Beta, typically near 0.5, suggests LIN's price movements are roughly half as volatile as the overall market.
    *   **Cap(B):**  Linde's market capitalization has steadily increased over the years, despite some fluctuations in performance.

**2) Recent Stock Price Fluctuations**

*   **Current Close:** 424.77
*   **Last-market:** {'price': 424.8267, 'previousClose': 424.8433, 'change': -0.0}
*   **5-day SMA:** 423.94
*   **20-day SMA:** 411.44
*   **60-day SMA:** 427.56

*   **Analysis:** The stock price is slightly above the 5-day and 20-day SMA but below the 60-day SMA. This suggests a potential short-term upward trend, but the price needs to break above the 60-day SMA to confirm a more sustained bullish signal. The very small change in the last market price indicates very little price movement recently.

**3) RSI, PPO, and Expected Return**

*   **MRI (Market Risk Indicator):** 1.0 (High Investment Recommended)
*   **RSI (Relative Strength Index):** 72.79 (Overbought)
*   **PPO (Percentage Price Oscillator):** 0.7365
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (2 shares - Safe (OverSold Boost) - MRI:0.80) Dividend_1.50 (Cash Ratio: 0% on 2025-12-03)
*   **Recent (20 days) relative divergence change:** 1.7 (+): 단기상승 (Short-term Increase)
*   **Expected Return (%):** 233.6%

*   **Analysis:**
    *   **MRI:** While the MRI suggests high investment, this indicator should be considered alongside other factors.
    *   **RSI:** An RSI above 70 indicates an overbought condition, suggesting the stock may be due for a pullback.
    *   **PPO:** The PPO is positive, which suggests a bullish trend.
    *   **Hybrid Signal:** The hybrid signal indicates a strong buy recommendation.
    *   **Expected Return:** The high expected return suggests significant potential upside from the current price level if held long-term.
    *   **Recent Divergence Change:** The short-term increase in relative divergence supports the bullish sentiment.

**4) Recent News & Significant Events**

*   **[2025-12-28]** "Linde (LIN) Stock News: Price, Analyst Forecasts, and Key Catalysts to Watch Ahead of the Next U.S. Trading Session" - Suggests a focus on upcoming catalysts and analyst views.
*   **[2025-12-05]** "How Investors Are Reacting To Linde (LIN) After Cramer’s Critique And New Credit Facility" - Implies some recent negative commentary followed by news of a new credit facility, which could be positive for future operations.
*   **[2025-12-26]** "Linde PLC $LIN Shares Acquired by Brookstone Capital Management" - Indicates institutional investor interest.
*   **[2025-11-13]** "Linde Stock Price Prediction: Is It a Buy, Sell, or Hold?" - Highlights uncertainty in the outlook.
*   **[2025-12-16]** "A Decade of Rewards: $44 Bil From Linde Stock" - Highlights long-term historical returns, but doesn't necessarily reflect current performance.
*   **[2025-12-05]** "Reassessing Linde (LIN) Valuation After Media Scrutiny on Its Recent Stock Underperformance" - Confirms recent underperformance and implies a possible re-evaluation of the stock's value.

*   **Analysis:** The news headlines paint a mixed picture. While some articles highlight positive aspects like institutional investment and historical returns, others focus on recent underperformance, media scrutiny, and valuation reassessments. The Cramer critique suggests there were potentially valid concerns raised about the stock. The new credit facility could be seen as a positive, providing financial flexibility.

**4-2) Analyst Opinions**

*   **Consensus:** Strong Buy
*   **Mean Rating:** 1.50 (Buy)
*   **Opinions:** 24
*   **Target Price (avg/high/low):** 502.71 / 565.00 / 381.00
*   **Recent Rating Changes:** No changes indicated.

*   **Analysis:** Despite the recent underperformance, analysts remain optimistic about LIN, with a "Strong Buy" consensus and a significant upside to the average target price. The target prices are significantly above the current stock price, reflecting potential investor optimism.

**5) Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-10-31 | 4.11 | 8.62 B$   |
| 2025-08-01 | 3.75 | 8.49 B$   |
| 2025-05-01 | 3.53 | 8.11 B$   |
| 2024-10-31 | 3.24 | 8.36 B$   |
| 2025-10-31 | 3.24 | 8.36 B$   |

*   **Analysis:**
    *   **EPS (Earnings Per Share):** EPS has generally been increasing, suggesting improved profitability on a per-share basis, except the last two quarters are identical.
    *   **Revenue:** Revenue has also generally increased over the past several quarters, indicating growth in sales.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-09-30   | $8.62B     | 49.17%        |
| 2025-06-30   | $8.49B     | 49.31%        |
| 2025-03-31   | $8.11B     | 48.75%        |
| 2024-12-31   | $8.28B     | 47.84%        |
| 2024-09-30   | $8.36B     | 47.87%        |

*   **Analysis:** Revenue has been increasing, and profit margins are relatively high and stable, indicating efficient operations.

**Capital and Profitability:**

| Quarter      | Equity     | ROE    |
|--------------|------------|--------|
| 2025-09-30   | $38.62B    | 5.00%  |
| 2025-06-30   | $38.52B    | 4.59%  |
| 2025-03-31   | $38.03B    | 4.40%  |
| 2024-12-31   | $38.09B    | 4.53%  |
| 2024-09-30   | $39.17B    | 3.96%  |

*   **Analysis:** Equity has remained relatively stable. ROE (Return on Equity) has been increasing, indicating improved profitability relative to shareholder equity.

**7) Comprehensive Analysis**

Linde PLC (LIN) presents a mixed investment picture.

**Strengths:**

*   **Strong Analyst Consensus:** Analysts have a "Strong Buy" consensus with a significant price target upside.
*   **Increasing Revenue & EPS:** Recent earnings show improvements in both revenue and earnings per share.
*   **High Profit Margins & Improving ROE:** The company demonstrates strong and improving financial performance in terms of profitability and return on equity.
*   **Hybrid Signal - Buy:** The Hybrid Signal suggests a buy recommendation, but should be viewed skeptically since it recommended "buy" at MRI:0.8 when the true MRI is now 1.0.
*   **Large Expected Return:** The data predicts significant gains in the long-term.

**Weaknesses:**

*   **Underperformance vs. S&P 500:** LIN has significantly underperformed the S&P 500.
*   **Negative Alpha & Recent CAGR Decline:** The recent Alpha values are negative, and CAGR is in decline.
*   **Overbought RSI:** The current RSI indicates the stock may be overbought and due for a pullback.
*   **Mixed News Sentiment:** News articles highlight concerns about valuation and underperformance.
*   **Contradictory Indicators:** MRI suggests high investment, but RSI indicates overbought conditions.

**Overall Assessment:**

The current recommendation is to perform additional due diligence. The strong analyst consensus and financial performance metrics are promising. However, the recent underperformance, overbought RSI, and negative news sentiment warrant caution. Investors should carefully weigh the potential risks and rewards before investing in LIN. It is important to understand the reasons behind the recent underperformance and whether those issues are likely to be resolved in the near future. The news article mentioning Cramer's critique should be investigated further to understand the specific concerns raised.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.